MASON STREET ADVISORS, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MASON STREET ADVISORS, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$274,000
+6.6%
13,640
-0.6%
0.01%0.0%
Q3 2020$257,000
-9.5%
13,718
+8.3%
0.01%
-16.7%
Q2 2020$284,000
+60.5%
12,661
+6.1%
0.01%
+50.0%
Q1 2020$177,000
-23.0%
11,9350.0%0.00%0.0%
Q4 2019$230,000
-0.9%
11,935
+2.0%
0.00%
-20.0%
Q3 2019$232,000
-6.8%
11,706
-0.7%
0.01%0.0%
Q2 2019$249,000
+9.7%
11,783
+6.1%
0.01%0.0%
Q1 2019$227,000
+6.1%
11,103
+3.4%
0.01%0.0%
Q4 2018$214,000
+8.1%
10,737
+4.5%
0.01%
+25.0%
Q3 2018$198,000
+25.3%
10,279
-0.8%
0.00%0.0%
Q2 2018$158,000
-14.1%
10,365
+5.5%
0.00%0.0%
Q1 2018$184,000
+4.0%
9,821
+6.7%
0.00%0.0%
Q4 2017$177,000
+9.9%
9,208
+2.2%
0.00%0.0%
Q3 2017$161,000
+2.5%
9,009
+2.4%
0.00%0.0%
Q2 2017$157,000
+28.7%
8,798
+4.8%
0.00%
+33.3%
Q1 2017$122,000
-15.9%
8,394
+7.0%
0.00%
-25.0%
Q4 2016$145,000
+18.9%
7,845
+21.5%
0.00%
+33.3%
Q3 2016$122,0006,4560.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders